| Pharmaceutical Information |
| Drug Name |
Flavoxate hydrochloride |
| Drug ID |
BADD_D00901 |
| Description |
A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist. [PubChem] |
| Indications and Usage |
For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis. |
| Marketing Status |
approved |
| ATC Code |
G04BD02 |
| DrugBank ID |
DB01148
|
| KEGG ID |
D00718
|
| MeSH ID |
D005422
|
| PubChem ID |
441345
|
| TTD Drug ID |
D0ND2J
|
| NDC Product Code |
42806-058; 24658-720; 65129-1015; 0574-0115 |
| UNII |
9C05J6089W
|
| Synonyms |
Flavoxate | Flavoxate Hydrochloride | Hydrochloride, Flavoxate | Urispas | Uronid | Bladuril | Spasuret |
|
| Chemical Information |
| Molecular Formula |
C24H26ClNO4 |
| CAS Registry Number |
3717-88-2 |
| SMILES |
CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
